OMESOV

Omeprazole-based acid suppression therapy for the treatment and management of GERD

Gastrointestinal Brand

OMESOV

OMESOV contains omeprazole and is used in the treatment of acid-related gastrointestinal conditions. It is available in capsules and an injectable formulation.

OMESOV packshot 1
OMESOV packshot 2

Therapeutic Category

Gastrointestinal

Dosage forms

Capsules and Injection

Strengths

20mg,40mg

Pack sizes

Pack of 10x10 Capsules, 1 vial+10mL Injection

Therapeutic Indications

  • Treatment and prevention of gastric and duodenal ulcers.
  • H. pylori eradication with appropriate antibiotics
  • Treatment and prevention of NSAID-associated ulcers
  • Treatment and long-term management of reflux oesophagitis
  • Relief of symptoms associated with gastro-oesophageal reflux disease (GERD)
  • Management of Zollinger–Ellison syndrome
OMESOV 20 packshot

Brand Name

OMESOV

Product Name

OMESOV 20

Generic Name

Omeprazole 20mg Capsules BP

Dosage Form

Capsules

Pack Size

Pack of 10x10 Capsules

OMESOV 20

Omeprazole 20mg Capsules BP

Therapeutic Indication

  • Indicated for the treatment of gastro-oesophageal reflux disease (GERD), gastric and duodenal ulcers, and other acid-related conditions

Dosage and Method of Administration

Adults:

  • GERD : 20 mg once daily for 4–8 weeks
  • Duodenal ulcer: 20 mg once daily for 2 weeks
  • Gastric ulcer: 20 mg once daily for 4 weeks
  • Prevention of recurrent gastric or duodenal ulcers: 20 mg once daily
  • NSAID-associated gastric or duodenal ulcers: 20 mg once daily for 4–8 weeks
  • Prevention of NSAID-associated ulcers: 20 mg once daily

Children:

≥ 1 year, weighing 10–20 kg: 20 mg once daily, if needed
≥ 2 years, weighing more than 20 kg: 20 mg once daily

Mode of Administration

For oral use only

OMESOV 40 packshot

Brand Name

OMESOV

Product Name

OMESOV 40

Generic Name

Omeprazole 40mg Injection

Dosage Form

Injection

Pack Size

Pack of 1 vial+10mL Injection

OMESOV 40

Omeprazole 40mg Injection

Therapeutic Indication

  • Indicated for the treatment of gastro-oesophageal reflux disease (GERD), gastric and duodenal ulcers, and other acid-related conditions

Dosage and Method of Administration

  • When oral treatment is not suitable: 40 mg once daily
  • Zollinger–Ellison syndrome Recommended starting dose: 60 mg once daily
  • Hepatic impairment : 10–20 mg once daily may be sufficient
  • Elderly patients: No dose adjustment required

Mode of Administration

For IV use only